Ditchcarbon
  • Contact
  1. Organizations
  2. Q-Med AB
Public Profile
Pharmaceutical Preparation Manufacturing
SE
updated 17 days ago

Q-Med AB Sustainability Profile

Company website

Q-Med AB, a pioneering company in the medical technology sector, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1988, Q-Med has established itself as a leader in the development of innovative hyaluronic acid-based products, particularly in the fields of aesthetics and regenerative medicine. The company’s flagship offerings include the renowned Restylane® range, which revolutionised facial aesthetics, and other advanced medical devices that enhance patient care. Q-Med's commitment to quality and scientific research has positioned it as a trusted name in the industry, with numerous accolades highlighting its contributions to healthcare. With a focus on improving patient outcomes, Q-Med continues to drive advancements in medical technology, solidifying its reputation as a key player in the global market.

DitchCarbon Score

How does Q-Med AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Q-Med AB's score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Q-Med AB's reported carbon emissions

Inherited from Galderma Group AG

Q-Med AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Galderma Group AG, which may influence its climate commitments and reporting practices. As of now, Q-Med AB has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of its parent company, Galderma Group AG, it is possible that Q-Med AB's climate commitments could align with broader initiatives undertaken by the group, although specific details are not available at this time. In summary, Q-Med AB's current climate commitments and emissions data remain unspecified, reflecting a potential area for future development in sustainability practices.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
9,800,000
0,000,000
Scope 2
4,200,000
000,000
Scope 3
-
000,000,000

How Carbon Intensive is Q-Med AB's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Q-Med AB's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Q-Med AB's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Q-Med AB is in SE, which has a very low grid carbon intensity relative to other regions.

Q-Med AB's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Q-Med AB has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Q-Med AB's Emissions with Industry Peers

Cogentix Medical, Inc.

US
•
Health and social work services (85)
Updated 27 days ago

Contura International A/S

DK
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 19 days ago

Carbon Medical Technologies, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy